Precision Nudging for Hypertension Management: Observational Study
Part of paid clinical trials in Greensboro, North Carolina.
- Sponsor
- Lirio
- Study ID
- NCT06354192
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Precision Nudging for Hypertension Management — BEHAVIORALThe hypertension digital health intervention under study combines behavioral science theory with a type of machine learning called reinforcement learning to enable precision nudging: the selection, assembly, and delivery of behavioral science-based messages created to address barriers to, and promote, management of hypertension. The behavioral design process used for the hypertension DHI intentionally includes research on traditionally underserved populations, such as racial and ethnic minorities and people with lower incomes or educational attainment. By including the right ingredients to meet a diverse set of needs and by effectively personalizing the content each individual sees based on their own reactions, the intervention aims to improve health equity by matching each individual to the right behavioral approach.
Study Details
The purpose of the proposed observational study is to explore the relations between data-driven personalization and equitable health outcomes in a digital health intervention (DHI) for hypertension management. In the current intervention, behavioral reinforcement learning is applied to personalize intervention content to maximize the behavioral outcomes of three target behaviors critical for effective hypertension management: clinical encounters, medication adherence, and self-monitoring of blood pressure (SMBP).
Key Dates
- Start date
- May 1, 2024
- Status verified
- Nov 2025
- Primary completion
- Apr 1, 2026
- Completion
- Nov 1, 2026
Study Design
- Enrollment
- 12,000 participants (estimated)
Arms
- Arm: Precision Nudging for Hypertension ManagementAll participants in this study will receive the digital health intervention.
Primary Outcome Measure
Clinical encounter behavioral outcome [ Time Frame: 0-18 months ]
Central Contacts
- Amy Bucher, PhD865-839-6158
- Sarah Deedat, PhD865-243-8000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cone Health clinics | Greensboro | North Carolina | 27401 |
Find similar trials in Greensboro, NC
By condition
By specialty
By research site
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE USRecruiting · Duke University · Charlotte, North Carolina